ARCHIVES

ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

NCI-Approved Clinical Trials

September 28, 2001

NCI Advisors Approve $20.5M Program Of Grants, Contracts For Biospecimen Research.

July 6, 2007

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999

NIH To Replace RAC With New Committee

July 19, 1996

AIDS Research Loan Repayment Program

January 10, 1992